← Back to All Filings

Natera Executive Donates 945 Common Shares via Charitable Gift

Low SignificanceSeptember 19, 2026 at 1:36:56 AM UTC

Natera, Inc.

$NTRA4CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Executive Donates 945 Common Shares via Charitable Gift

Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2026/09/19 Significance: Low

Insider: Solomon Moshkevich Title: President, Clinical Diagnostics | Relationship: Officer

Transaction: • Type: Gift (Charitable Donation) • Shares: 945 • Price: $0.00 • Value: $0.00 • Owned After: 109,914 shares

Key Insight: Routine charitable gift representing less than 0.001% of Natera's outstanding shares and less than 1% of the executive's total equity holdings.

Market Context: Transaction represents zero market impact and no change in corporate operational outlook.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: President of Clinical Diagnostics Solomon Moshkevich transferred 945 shares as a bona fide charitable gift, reflecting no open-market selling activity.
  • Market Impact: Neutral; immaterial transaction volume with zero cash proceeds.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustryServices-Medical Laboratories

Insider Information

FieldValue
NameSolomon Moshkevich
CIK0002010019
Title/PositionPresident, Clinical Diagnostics
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-09-16
Transaction CodeG (Gift)
Security TypeCommon Stock
Shares Involved945
Price Per Share$0.00
Total Value$0.00
Shares Owned After109,914
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0.00
% of Market Cap ($49.27B)0.000%
Shares Transacted945
% of Shares Outstanding (143.22M)0.00066%
Post-Transaction Ownership109,914 shares (0.077%)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap diagnostic provider with a market capitalization of $49.27B, a transfer of 945 shares is negligible.
  • Ownership Concentration: The executive maintains 109,914 directly owned shares (~0.08% of total float), indicating strong continued alignment.
  • Dilution Impact: None; existing shares were transferred rather than newly issued.
  • Transaction Significance: Low significance given the transaction code 'G' (charitable contribution) and nominal size.

Market Impact Analysis

  • Direction: Neutral
  • Reasoning: Charitable gifts do not reflect management sentiment or fundamental corporate performance.
  • Expected Volume Impact: Negligible to none.
  • Sentiment Indicator: Neutral

Additional Context

  • Footnote Analysis: Footnote 1 confirms the disposition represents a bona fide charitable contribution.
  • Trading Plan: Not conducted under a Rule 10b5-1 trading plan.
Topics:#SECFiling#Form4#NTRA#Natera#CharitableGift#InsiderTrading#StockAlert#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.